Establishment of monoclonal antibodies against human nerve growth factor

Biochem Biophys Res Commun. 1993 Nov 15;196(3):1474-80. doi: 10.1006/bbrc.1993.2418.

Abstract

We have generated and characterized a monoclonal antibody to human nerve growth factor (hNGF). The monoclonal antibody NGFA-133 neutralizes hNGF activity, as assayed by neurite-outgrowth of nerve cells from chick embryonal dorsal root ganglion. Using this antibody, we have developed a sensitive and specific two-site enzyme immunoassay (EIA) system for hNGF. The assay is based on a sandwiching of the antigen between NGFA-133 coated on a microtiter plate and the same monoclonal antibody (NGFA-133) conjugated with horseradish peroxidase (HRP). The two-site EIA was sensitive enough to detect 920 fg/well of hNGF and did not cross-react either human neurotrophin-3 (hNT-3) or sodium dodecyl sulfate (SDS) denatured hNGF.

MeSH terms

  • Animals
  • Antibodies / isolation & purification
  • Antibodies, Monoclonal* / isolation & purification
  • Biological Assay
  • Cells, Cultured
  • Chick Embryo
  • Cross Reactions
  • Female
  • Ganglia, Spinal / cytology
  • Humans
  • Immunoenzyme Techniques
  • Mice
  • Mice, Inbred BALB C / immunology
  • Nerve Growth Factors / analysis*
  • Nerve Growth Factors / immunology
  • Nerve Growth Factors / pharmacology
  • Neurons / drug effects
  • Neutralization Tests
  • PC12 Cells
  • Protein Denaturation
  • Rabbits / immunology

Substances

  • Antibodies
  • Antibodies, Monoclonal
  • Nerve Growth Factors